MedPath

Guided smartphone-based treatment for patients in opioid maintenance treatme

Not Applicable
Conditions
Moderate to severe opioids use disorder.
Opioid dependence
F11.2
Registration Number
IRCT20170702034844N8
Lead Sponsor
Swiss Research Institute of Public Health and Addiction (ISGF)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
400
Inclusion Criteria

Written informed consent
Minimal age of 18 years
Stabilization on methadone or buprenorphine dosage for at least 3 weeks
Ownership of a smartphone and a valid email address
Good command of Persian
Appropriate geographical access to the study site in Tehran

Exclusion Criteria

Concurrent benzodiazepine, (meth-)amphetamine, or cocaine dependence
Current pharmacologically-treated severe psychiatric disease, like schizophrenia or bipolar type I disorder, or significant current suicidal or homicidal thoughts

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Weekly negative urine tests for morphine. Timepoint: Between each measurement point (months 1-3, months 6 and 12 ). Method of measurement: Urine rapid test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath